Your browser doesn't support javascript.
loading
Hypoxia as a driver of resistance to immunotherapy.
Kopecka, Joanna; Salaroglio, Iris C; Perez-Ruiz, Elizabeth; Sarmento-Ribeiro, Ana Bela; Saponara, Simona; De Las Rivas, Javier; Riganti, Chiara.
Afiliação
  • Kopecka J; Department of Oncology, University of Torino, Italy.
  • Salaroglio IC; Department of Oncology, University of Torino, Italy.
  • Perez-Ruiz E; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.
  • Sarmento-Ribeiro AB; Laboratory of Oncobiology and Hematology and University Clinic of Hematology and Coimbra Institute for Clinical and Biomedical Research - Group of Environment Genetics and Oncobiology (iCBR/CIMAGO), Faculty of Medicine, University of Coimbra (FMUC), Center for Innovative Biomedicine and Biotechnolog
  • Saponara S; Department of Life Sciences, University of Siena, Italy.
  • De Las Rivas J; Cancer Research Center (CiC-IBMCC, CSIC/USAL/IBSAL), Consejo Superior de Investigaciones Científicas (CSIC), University of Salamanca (USAL), and Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
  • Riganti C; Department of Oncology, University of Torino, Italy. Electronic address: chiara.riganti@unito.it.
Drug Resist Updat ; 59: 100787, 2021 12.
Article em En | MEDLINE | ID: mdl-34840068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article